{"address1": "490 Arsenal Way", "address2": "Suite120", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "617 231 0700", "website": "https://www.c4therapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is Cemsidomide, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma, currently under Phase 1/2 clinical trials. The company is also developing CFT1946, an orally bioavailable BiDAC degrader targeting BRAF V600 mutant to treat melanoma, colorectal cancer, and other solid malignancies, currently under Phase 1/2 clinical trials; and CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC under preclinical stage. It has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; Betta Pharmaceuticals, Co., Ltd.; Merck KGaA, Darmstadt, Germany; and Merck Sharp & Dohme, LLC, as well as Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 110, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew J. Hirsch M.B.A.", "age": 53, "title": "CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 986078, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kenneth C. Anderson M.D., Ph.D.", "age": 73, "title": "Co-Founder, Independent Director & Member of Scientific Advisory Board", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stewart  Fisher Ph.D.", "age": 56, "title": "Consultant", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 674572, "exercisedValue": 0, "unexercisedValue": 181975}, {"maxAge": 1, "name": "Dr. Leonard M. J. Reyno M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 1040820, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nathanael S. Gray Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendra  Adams", "title": "CFO & Treasurer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Mossler", "age": 50, "title": "Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paige  Mahaney Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Courtney  Solberg", "title": "Senior Manager of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jolie M. Siegel J.D.", "age": 47, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 610400, "exercisedValue": 1063000, "unexercisedValue": 1335958}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.6, "open": 1.58, "dayLow": 1.43, "dayHigh": 1.58, "regularMarketPreviousClose": 1.6, "regularMarketOpen": 1.58, "regularMarketDayLow": 1.43, "regularMarketDayHigh": 1.58, "payoutRatio": 0.0, "beta": 2.998, "forwardPE": -0.83918124, "volume": 909110, "regularMarketVolume": 909110, "averageVolume": 1488560, "averageVolume10days": 851500, "averageDailyVolume10Day": 851500, "bid": 1.4, "ask": 1.47, "bidSize": 2, "askSize": 6, "marketCap": 101870208, "fiftyTwoWeekLow": 1.43, "fiftyTwoWeekHigh": 8.08, "priceToSalesTrailing12Months": 2.8628094, "fiftyDayAverage": 2.7655, "twoHundredDayAverage": 4.66375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -77277840, "profitMargins": -2.9596398, "floatShares": 47248589, "sharesOutstanding": 70989696, "sharesShort": 8173895, "sharesShortPriorMonth": 8059122, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.115100004, "heldPercentInsiders": 0.11508001, "heldPercentInstitutions": 0.91496, "shortRatio": 5.8, "shortPercentOfFloat": 0.1393, "impliedSharesOutstanding": 70989696, "bookValue": 3.058, "priceToBook": 0.46926093, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -105316000, "trailingEps": -1.52, "forwardEps": -1.71, "enterpriseToRevenue": -2.172, "enterpriseToEbitda": 0.67, "52WeekChange": -0.8183544, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.435, "targetHighPrice": 50.0, "targetLowPrice": 3.0, "targetMeanPrice": 15.5625, "targetMedianPrice": 12.0, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 244904000, "totalCashPerShare": 3.45, "ebitda": -115359000, "totalDebt": 65756000, "quickRatio": 5.49, "currentRatio": 5.706, "totalRevenue": 35584000, "debtToEquity": 30.445, "revenuePerShare": 0.513, "returnOnAssets": -0.20174, "returnOnEquity": -0.45581, "grossProfits": -75053000, "freeCashflow": -35434624, "operatingCashflow": -65157000, "revenueGrowth": 0.588, "grossMargins": -2.10918, "ebitdaMargins": 0.0, "operatingMargins": -7.2839503, "financialCurrency": "USD", "symbol": "CCCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "shortName": "C4 Therapeutics, Inc.", "longName": "C4 Therapeutics, Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_321572356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -10.312505, "regularMarketPrice": 1.435, "cryptoTradeable": false, "marketState": "PRE", "regularMarketChange": -0.16500008, "regularMarketDayRange": "1.43 - 1.58", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1488560, "fiftyTwoWeekLowChange": 0.004999995, "fiftyTwoWeekLowChangePercent": 0.0034965002, "fiftyTwoWeekRange": "1.43 - 8.08", "fiftyTwoWeekHighChange": -6.645, "fiftyTwoWeekHighChangePercent": -0.822401, "fiftyTwoWeekChangePercent": -81.83544, "earningsTimestamp": 1740663000, "earningsTimestampStart": 1746534600, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.52, "epsForward": -1.71, "epsCurrentYear": -1.64158, "priceEpsCurrentYear": -0.8741578, "fiftyDayAverageChange": -1.3305001, "fiftyDayAverageChangePercent": -0.48110652, "twoHundredDayAverageChange": -3.2287502, "twoHundredDayAverageChangePercent": -0.6923077, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "displayName": "C4 Therapeutics", "trailingPegRatio": null}